Background Biliary atresia (BA) is a severe inflammatory obliterative cholangiopathy of
infancy that requires early diagnosis and prompt surgical intervention. In this study, we …

Background Biliary obstruction leads to an increase in biliary pressure within the biliary
system, which induces the morphologic adaptation of the biliary tree. Purpose To observe …

Following Kasai hepatic portoenterostomy (HPE), most patients with biliary atresia will
eventually require liver transplantation due to progressive cirrhosis and liver failure …

Background: Biliary atresia (BA) is likely caused by a common phenotypic response to
various triggers; one proposed trigger, cytomegalovirus (CMV), may lead to worse …

Background Biliary atresia (BA) is a childhood liver disease characterized by fibrous
obstruction and obstruction of the extrahepatic biliary system and is one of the most common …

Aims In RCT of adults with decompensated cirrhosis, GCSF mobilizes hematopoietic stem
cells HSC and improves short-term outcome. An FDA-IND for sequential Kasai-GCSF …

Abbreviations: α-SMA, alpha-smooth muscle; A1AT, alpha-1 antitrypsin; AALD, alcohol-
associated liver disease; AATD, alpha-1 antitrypsin deficiency; ACE2, angiotensin 1 …

We investigated noninvasive follow‐up markers for histologic liver fibrosis and portal
hypertension (PH) in patients with biliary atresia after successful portoenterostomy (PE) …

Background & Aims Syndromic biliary atresia is a cholangiopathy characterized by fibro-
obliterative changes in the extrahepatic bile duct (EHBD) and congenital malformations …

Cirrhotic cardiomyopathy (CCM), a comorbidity of end‐stage cirrhotic liver disease, remains
uncharacterized in children, largely because of a lack of an established pediatric definition …